| Q41083001 | ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement |
| Q37848211 | Asymptomatic aortic stenosis: when to operate? |
| Q26740242 | Asymptomatic severe aortic stenosis with normal left ventricular function - A review |
| Q38811578 | Asymptomatic severe aortic stenosis: challenges in diagnosis and management |
| Q38762609 | Biomarkers of Calcific Aortic Valve Disease |
| Q27027825 | Care of patients with apparently asymptomatic severe aortic valve stenosis |
| Q38746257 | Changing concept in treatment of asymptomatic severe aortic stenosis and normal ejection fraction: time for biomarkers reappraisal |
| Q90476010 | Clinical Prediction Models for Valvular Heart Disease |
| Q48332698 | Comparing characteristics and clinical and echocardiographic outcomes in low-flow vs normal-flow severe aortic stenosis with preserved ejection fraction in an Asian population. |
| Q38958856 | Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) Study |
| Q30435363 | Current management of calcific aortic stenosis |
| Q64938699 | Echocardiographic Evaluation of Aortic Stenosis - Normal Flow and Low Flow Scenarios. |
| Q35782067 | Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis |
| Q33905365 | Evaluation of aortic stenosis severity using 4D flow jet shear layer detection for the measurement of valve effective orifice area |
| Q38435985 | Evaluation of aortic stenosis: an update--including low-flow States, myocardial mechanics, and stress testing |
| Q37841212 | Exercise hemodynamics in valvular heart disease |
| Q38205777 | Exploring the biology of valvular heart disease: Time to move into the twenty-first century |
| Q42769846 | Factors affecting the technical efficiency of health systems: A case study of Economic Cooperation Organization (ECO) countries (2004-10). |
| Q42870520 | Grading aortic stenosis severity when the flow modifies the gradientvalve area correlation |
| Q89251344 | Heart Valve Disease Awareness Survey 2017: what did we achieve since 2015? |
| Q50101137 | Heart valve disesases : How sufficient is the knowledge of the German population? |
| Q41627486 | Impact of Vascular Hemodynamics on Aortic Stenosis Evaluation: New Insights Into the Pathophysiology of Normal Flow-Small Aortic Valve Area-Low Gradient Pattern |
| Q48283986 | Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study |
| Q41183736 | Low gradient aortic stenosis |
| Q92049460 | Low systemic arterial compliance is associated with increased cardiovascular morbidity and mortality in aortic valve stenosis |
| Q39698352 | Low-flow aortic stenosis and preserved left ventricular ejection fraction |
| Q38215381 | Markers of left ventricular decompensation in aortic stenosis. |
| Q58554409 | Multimarker Approach to Identify Patients With Higher Mortality and Rehospitalization Rate After Surgical Aortic Valve Replacement for Aortic Stenosis |
| Q38899696 | Multimodality imaging for the diagnosis and assessment of aortic stenosis severity |
| Q57039024 | Outcomes of Patients With Asymptomatic Aortic Stenosis Followed Up in Heart Valve Clinics |
| Q48355620 | Predicting changes in flow category in patients with severe aortic stenosis and preserved left ventricular ejection fraction on medical therapy. |
| Q38663699 | Prognostic Impact of Peak Aortic Jet Velocity in Conservatively Managed Patients With Severe Aortic Stenosis: An Observation From the CURRENT AS Registry |
| Q30381811 | Prognostic Value of Aortic Valve Area by Doppler Echocardiography in Patients With Severe Asymptomatic Aortic Stenosis. |
| Q46075608 | Prognostic Value of E/E′ Ratio in Patients With Unoperated Severe Aortic Stenosis |
| Q44093893 | Prognostic stratification by conventional echocardiography of patients with aortic stenosis: the "CAIMAN-ECHO score". |
| Q37448642 | Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations |
| Q35785968 | Relation between E/e' ratio and NT-proBNP levels in elderly patients with symptomatic severe aortic stenosis |
| Q36287921 | Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis |
| Q47700751 | SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis |
| Q36877646 | Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis. |
| Q50915456 | The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach. |
| Q38743657 | The role of cardiac biochemical markers in aortic stenosis. |
| Q38989945 | Timing of Dynamic NT-proBNP and hs-cTnT Response to Exercise Challenge in Asymptomatic Children with Moderate Aortic Valve Regurgitation or Moderate Aortic Valve Stenosis |
| Q38737143 | Treatment of asymptomatic aortic valve stenosis : Watchful waiting or early intervention? |
| Q33886913 | Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis |
| Q38066572 | Viewpoint: the ENIGMAS trial - when should we treat patients with moderate aortic stenosis? |